Company profile
Hebei Senlang Biotechnology company profile
Hebei Senlang Biotechnology is focused on the treatment of immune cells new technology development and application of high-tech enterprises.The company has the CAR-T research base (Senrang CAR-T Research Center) in North China, and has formed a high-barrier technology platform such as innovative CAR structural design, virus and cell culture , which can take into account technical research and development, hospital clinical application Provide high-quality and effective cellular immunotherapy support for hematological tumors, solid tumors and other tumor diseases, immune system diseases and other patients.
Business identity
- Phone number
- +86-311-82970975
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 51-100 employees
- Revenue range
- $1M-$10M
- Founded
- 2016-01-01, Year
Headquarters
- Headquarters
- Duru, Guizhou, China
- Country code
- CN
- Continent
- Asia